According to the literature,10 a plausible reaction mechanism
is outlined in Scheme 2. First, the alkynylbenzonitrile 1a is
activated by copper catalyst to form the Cu(Ⅱ) complex A. Then,
2-iodo-5-methylaniline 2c reacts with the activated
alkynylbenzonitrile to produce the intermediate
B
via
nucleophilic addition reaction.11 The intermediate B undergoes an
intramolecular nucleophilic addition on the copper-activated
triple bond, giving rise to the cyclic intermediate C. Finally, the
intermediate C undergoes a KOtBu-initiated deprotonation to
generate carbanion D,12 which leads to the desired product 3c via
a nucleophilic aromatic substitution reaction.
a Reaction conditions: 1 (0.36 mmol), 2a (0.3 mmol), Cu(OAc)2 (10 mmol
%), KOtBu (0.9 mmol), DMAc (1 mL), under the N2 atmosphere in a sealed
Schlenk tube, at 120 oC for 12 h.
Spectroscopic
properties
of
benzo[4,5]imidazo[2,1-
Scheme 2. Plausible Mechanism
a]isoquinolines were further investigated by measurements of
three representative compounds 3a, 3w, and 3j. Photochemical
data shown in Table 4 revealed that, due to structure hybrid
characteristic, typical absorption of both isoquinoline and
benzimidazoles could not be found in the absorption spectra, but
they possessed absorption bands centered at about 338-375 nm.
Moreover, as depicted in Figure 1, in comparison with the
maximum emission peaked at 386 nm of isoquinoline in DCM
solution, the bathochromic-shift fluorescence appeared for these
derivatives, which would be attributed to their improved
conjugate structure.
In summary, we have demonstrated a novel copper-catalyzed
method for the synthesis of benzo[4,5]imidazo[2,1-
a]isoquinolines from o-alkynylbenzonitriles and 2-iodoanilines.
In this reaction, three different C−N bonds are sequentially
formed through the cleavage of one C-I bond and two N-H
bonds. Notably, this project can selectively synthesize a series of
isoquinoline-fused benzimidazoles, which make it appealing for
application to the synthesis of important natural products,
pharmaceuticals, and functional materials.
Acknowledgments
Table 4. Spectroscopic Properties of 6-Phenylbenzo[4,5]-
imidazo[2,1-a]isoquinolines a
This work was supported by the Natural Science Foundation of
China (21572051, 21602057), Education Department of Hunan
Province (15A109), Opening Fund of Key Laboratory of
Chemical Biology and Traditional Chinese Medicine Research
(Ministry of Education of China), Hunan Normal University
(KLCBTCMR201707, KLCBTCMR201708), Hong Kong
Scholars program (XJ2017009) for financial support.
Stokes
shift(nm)
φf b
Absmax ε×103(L·mol- Emission
Compd
(nm)
1·cm-1)
max(nm)
3a
3w
3j
308
348
375
290
309
338
237
241
6.90
6.77
6.10
6.52
8.29
8.14
6.82
7.03
431
83
74
0.584
449
455
0.778
0.578
117
References and notes
4
5
386
-
-
-
-
-
1 (a) Colotta, V.; Catarzi, D.; Varano, F.; Cecchi, L.; Filacchioni, G.;
Martini, C.; Trincavelli, L.; Lucacchini, A. J. Med. Chem. 2000, 43, 3118.
(b) Deady, L. W.; Rodemann, T.; Finlay, G. J.; Baguley, B. C.; Denny, W.
A. Anti-Cancer Drug Des. 2000, 15, 339. (c) Horton, D. A.; Bourne, G. T.;
Smythe, M. L. Chem. Rev. 2003, 103, 893. (d) Hymel, D.; Woydziak, Z. R.;
Peterson, B. R. J. Am. Chem. Soc. 2014, 136, 5241.
a Measured in DCM. b Measured with quinine sulphate as a standard. 4
(isoquinoline), 5 (benzimidazole).
Figure 1. Normalized Fluorescence (bottom) Spectra
4
1.0
3a
2 (a) Rida, S. M.; El-Meligy, S. A. M.; Fahmy, H. T. Y.; Hazzaa, A. A.; El-
Meligy, M. M. M. Arch. Pharmacal Res. 2006, 29, 826. (b) Lenzi, O.;
Colotta, V.; Catarzi, D.; Varano, F.; Squarcialupi, L.; Filacchioni, G.;
Varani, K.; Vincenzi, F.; Borea, P. A.; Dal Ben, D.; Lambertucci, C.;
Cristalli, G. Bioorg. Med. Chem. 2011, 19, 3757.
3w
3j
0.8
0.6
0.4
0.2
0.0
3
(a) Geerts, Y.; Quante, H.; Platz, H.; Mahrt, R.; Hopmeier, M.; Böhm, A.;
Müllen, K. J. Mater. Chem. 1998, 8, 2357. (b) Tao, Y. T.;
Balasubramaniam, E.; Danel, A.; Jarosz, B.; Tomasik, P. Chem. Mater.
2001, 13, 1207. (c) Qian, G.; Wang, Z. Chem. Asian J. 2010, 5, 1006.
360 420 480 540 600
Wavelength/nm
4 (black), 3a (blue), 3w (green) and 3j (red) measured in DCM.
4 (a) Patil, N. T.; Mutyala, A. K.; Lakshmi, P. G. V. V.; Raju, P. V.
K.; Sridhar, B. Eur. J. Org. Chem. 2010, 10, 1999. (b) Ouyang, H.-
C.; Tang, R.-Y.; Zhong, P.; Zhang, X.-G.; Li, J.-H. J. Org. Chem.